{
    "clinical_study": {
        "@rank": "67090", 
        "arm_group": {
            "arm_group_label": "dexmedetomidine", 
            "arm_group_type": "Experimental", 
            "description": "After intravenous infusion of dexmedetomidine for 2 min, propofol 2.0 mg/kg was administrated. And laryngeal mask airway device was inserted(LMA # 3,4)."
        }, 
        "brief_summary": {
            "textblock": "The investigators attempted to determine the optimal dose of dexmedetomidine required for\n      the successful insertion of LMA during propofol induction without a neuromuscular blocking\n      agent."
        }, 
        "brief_title": "Dexmedetomidine for Laryngeal Mask Airway Insertion", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Drug Usage", 
        "detailed_description": {
            "textblock": "After a predetermined bolus dose of dexmedetomidine was injected over 2 min, anesthesia was\n      induced with propofol 2.0 mg/kg.  After confirming the loss of eyelash reflex and the\n      bispectral index (BIS) score decreased below 60, the insertion of LMA was attempted."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I-II patients undergoing general anesthesia for short elective surgery (<1 hr)\n\n        Exclusion Criteria:\n\n          -  G-E reflux\n\n          -  obesity (BMI>30)\n\n          -  anticipated difficult airway"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852539", 
            "org_study_id": "AJIRB-MED-CT4-13-045"
        }, 
        "intervention": [
            {
                "arm_group_label": "dexmedetomidine", 
                "description": "The dose of dexmedetomidine was determined by modified Dixon's up-and-down method, starting from 0.5 \u03bcg/kg (0.1 \u03bcg/kg as a step size).", 
                "intervention_name": "dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "precedex"
            }, 
            {
                "arm_group_label": "dexmedetomidine", 
                "description": "Propofol 2.0 mg/kg was administrated", 
                "intervention_name": "propofol", 
                "intervention_type": "Drug", 
                "other_name": "2% fresofol"
            }, 
            {
                "arm_group_label": "dexmedetomidine", 
                "description": "The insertion of laryngeal mask airway (LMA) was attempted, after confirming the loss of eyelash reflex,the bispectral index (BIS) score decreased below 60.", 
                "intervention_name": "laryngeal mask airway (LMA)", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Propofol", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "LMA insertion", 
            "dexmedetomidine", 
            "propofol"
        ], 
        "lastchanged_date": "April 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "zip": "443-721"
                }, 
                "name": "Ajou University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Optimal Dose of Dexmedetomidine for Laryngeal Mask Airway Insertion During Propofol Induction", 
        "overall_official": {
            "affiliation": "Ajou University School of Medicine", 
            "last_name": "Jong Yeop Kim, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "the response of patients to the insertion of LMA (classified as either 'movement' or 'no movement') during infusion of dexmedetomidine and propofol.", 
            "measure": "successful insertion of LMA", 
            "safety_issue": "Yes", 
            "time_frame": "from baseline to 2 min after insertion of LMA (participants will be followed for the duration of anesthetic induction, an expected average of 10 min)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852539"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ajou University School of Medicine", 
            "investigator_full_name": "Jong Yeop Kim", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "18400141", 
            "citation": "Uz\u00fcmc\u00fcgil F, Canbay O, Celebi N, Karagoz AH, Ozgen S. Comparison of dexmedetomidine-propofol vs. fentanyl-propofol for laryngeal mask insertion. Eur J Anaesthesiol. 2008 Aug;25(8):675-80. doi: 10.1017/S0265021508004213. Epub 2008 Apr 10."
        }, 
        "source": "Ajou University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ajou University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}